<http://webisa.webdatacommons.org/407071912>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<fda.gov> .
<http://webisa.webdatacommons.org/407071912>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/407071912>	<http://www.w3.org/ns/prov#value>	"This side favors control that there was an increased risk with the hemoglobin-based blood substitute, this side says there was benefit." .
<http://webisa.webdatacommons.org/prov/73330328>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/407071912> .